COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Characteristics of Critically Ill COVID 19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04465058
Recruitment Status : Recruiting
First Posted : July 9, 2020
Last Update Posted : July 9, 2020
Information provided by (Responsible Party):
Rasha Hamed, Assiut University

Brief Summary:
COVID19 is n outbreak with unpredictable outcome

Condition or disease Intervention/treatment
COVID19 Other: COVID19

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Clinical Characteristics and Outcome in Critically Ill COVID 19 Patients
Actual Study Start Date : July 8, 2020
Estimated Primary Completion Date : August 8, 2020
Estimated Study Completion Date : August 10, 2020

Intervention Details:
  • Other: COVID19
    viral infection

Primary Outcome Measures :
  1. clinical characteristics [ Time Frame: 48 hours ]
    measurements of arterial blood gas

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
crirical patients need oxygen therapy

Inclusion Criteria:

  • COVID 19 patients need oxygen therapy

Exclusion Criteria:

  • patients does not need oxygen therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04465058

Layout table for location information
Assiut university Recruiting
Assiut, Egypt, 71111
Contact: rasha hamed, MD    0882413201    rashaahmed11@yahoo.nom   
Sponsors and Collaborators
Assiut University
Layout table for additonal information
Responsible Party: Rasha Hamed, lecturer of anaesthesia, Assiut University Identifier: NCT04465058    
Other Study ID Numbers: yte
First Posted: July 9, 2020    Key Record Dates
Last Update Posted: July 9, 2020
Last Verified: July 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Critical Illness
Disease Attributes
Pathologic Processes